AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?
about
The sweet trap in tumors: aerobic glycolysis and potential targets for therapyHigh metastaticgastric and breast cancer cells consume oleic acid in an AMPK dependent manner.Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?Targeting AMPK for cancer prevention and treatment.The role of adiponectin signaling in metabolic syndrome and cancer.Proteomics and metabolomics in cancer drug development.Activators of AMPK: not just for type II diabetes.6-Gingerol modulates proinflammatory responses in dextran sodium sulfate (DSS)-treated Caco-2 cells and experimental colitis in mice through adenosine monophosphate-activated protein kinase (AMPK) activation.5-Aminoimidazole-4-carboxamide ribonucleoside-mediated adenosine monophosphate-activated protein kinase activation induces protective innate responses in bacterial endophthalmitis.Liver-Specific Activation of AMPK Prevents Steatosis on a High-Fructose Diet.AMPK activity is down-regulated in endothelial cells of GHS-R(-/-) mice.Sodium salicylate modulates inflammatory responses through AMP-activated protein kinase activation in LPS-stimulated THP-1 cells.The Effects of Berberine on Concanavalin A-Induced Autoimmune Hepatitis (AIH) in Mice and the Adenosine 5'-Monophosphate (AMP)-Activated Protein Kinase (AMPK) Pathway.Pioglitazone Attenuates Injury-Induced Neointima Formation in Mouse Femoral Artery Partially through the Activation of AMP-Activated Protein Kinase.Phosphorylation of Janus kinase 1 (JAK1) by AMP-activated protein kinase (AMPK) links energy sensing to anti-inflammatory signaling.Identification of a novel 2-oxindole fluorinated derivative as in vivo antitumor agent for prostate cancer acting via AMPK activation.Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy.
P2860
Q26766079-17AD6AF3-2DA3-42D9-A7E5-587BC9285D51Q33604988-74C7AB7E-BD00-431D-8175-1A6916E30CE1Q34482056-0BC813C5-E782-4452-9766-72A84D66690BQ35781311-088A255D-77BF-485F-8BDA-52B4923F6BB0Q38135763-394427D4-B0A2-4468-9DB8-771B010DAB01Q38151765-DE479A52-7594-4BEB-85CB-11327689C7E8Q38243893-789D8A6A-72F7-470A-BB1E-08858B26E5D9Q38844522-9B597B96-A08D-4861-96AB-8F6A52253F27Q40644641-8E1301E3-17E8-432C-B537-7F402D4DEBFAQ41775145-711678F5-FB10-4018-8AF3-AA1442E006C7Q42580149-286B72EE-2E01-485C-95A2-4965C1EBDB33Q47144580-BBD9818D-150D-4D01-B253-53AD86E2916EQ47249597-A57D8B2C-DFD7-45A0-837F-71409A8FDD8AQ51014952-63BBF6A0-C819-4123-862F-3AC5395DAA94Q51284981-697A3792-91FA-4236-90FB-4E90297323AAQ52659506-073E7BAB-8294-43FB-9BEF-E0D442D144C2Q52661722-C0154828-D92D-41CE-B3A9-0024A0840F34
P2860
AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?
@ast
AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?
@en
AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?
@nl
type
label
AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?
@ast
AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?
@en
AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?
@nl
prefLabel
AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?
@ast
AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?
@en
AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?
@nl
P2860
P356
P1476
AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?
@en
P2093
D. Grahame Hardie
Madhumita Dandapani
P2860
P304
P356
10.1042/BST20120351
P407
P577
2013-04-01T00:00:00Z